Harold H Handley, Jr

Title: The Innovative Contributions of Harold H Handley, Jr.

Introduction

Harold H Handley, Jr. is a notable inventor based in Encinitas, California, recognized for his significant contributions to medical technology. With a total of nine patents, he has developed groundbreaking inventions that enhance procedures in plasmapheresis, a vital blood purification process.

Latest Patents

Among his latest patents, Handley has introduced an "Apparatus and method for in-vivo plasmapheresis using periodic backflush containing anticoagulant." This method details how to utilize elongated hollow microporous filter fibers to periodically interrupt the diffusion of blood plasma from a patient. The innovative design involves directing backflush fluid into the fibers, applying a pressure that effectively cleanses the fiber pores. The backflush fluid usually consists of a normal saline solution combined with anticoagulants like heparin or citrate, enabling better systemic anti-coagulation and fiber thromboresistance.

Additionally, he has patented "Specialized hollow fiber membranes for plasmapheresis and ultrafiltration." This invention describes a membrane made of elongated hollow fibers, designed with varying mass densities along their walls. The unique structure of these fibers promotes enhanced performance in plasmapheresis and ultrafiltration processes.

Career Highlights

Handley's career is marked by a commitment to improving medical procedures through innovative technologies. His role at Transvivo, Inc. has allowed him to pursue his passion for developing effective medical devices that support patient care and outcomes.

Collaborations

Throughout his career, Handley has worked alongside accomplished colleagues, including Reynolds G Gorsuch and Harold W Peters. These collaborations have fostered a productive environment for innovation, driving advancements in the field of medical technology.

Conclusion

Harold H Handley, Jr. stands out as a prominent figure in the realm of medical inventions. With his extensive patent portfolio and collaborative spirit at Transvivo, Inc., he continues to lead the way in developing solutions that improve plasmapheresis methods, ultimately benefiting patients and the healthcare industry as a whole.